Business / Finance

RSS

Consumer focus on health and well-being drive demand for L-carnitine market

Consumer focus on health and well-being have driven demand for the L-carnitine market, an amino acid understood to provide distinct health benefits, according to a new report on companiesandmarkets.com. By 2017, it is expected that the L-carnitine market will achieve a value of $127.7 million.

21 Jun 2011

Merge completes $52M Senior Secured Notes offering

Merge Healthcare Incorporated today announced the successful completion of its previously announced private offering of $52 million in aggregate principal amount of its 11.75% Senior Secured Notes due 2015.

21 Jun 2011

bioMD (BOD) announces new MD, new Chairman and Board

bioMD Limited (ASX:BOD), a company with assets in regenerative tissue engineering technologies today announced the appointment of a new Chairman, a new MD and other changes to its Board. This follows shareholder approval for the acquisition of Allied Medical Ltd., a company that specialises in the sales, distribution and commercialisation of medical technologies.

20 Jun 2011

Endo acquires American Medical Systems for $2.9 billion in cash

Endo Pharmaceuticals announced today the completion of its acquisition of American Medical Systems, Inc. (AMS). Endo announced on April 11, 2011, that it entered into a definitive agreement to acquire AMS, a leading provider of world-class devices and therapies for male and female pelvic health, for approximately $2.9 billion in cash.

20 Jun 2011

Derma Sciences to raise $29M through private placement

Derma Sciences, Inc., a medical device and pharmaceutical company focused on advanced wound care, today announced it has entered into definitive agreements with select institutional investors to raise gross proceeds of approximately $29 million.

20 Jun 2011

NanoViricides plans to lease new cGMP manufacturing and lab space

NanoViricides, Inc. announced today that it will be leasing new space for cGMP production of its nanoviricides drug candidates against various viral diseases.

20 Jun 2011

Panacea Global announces name change

Panacea Global Inc.,, a biopharmaceutical company specializing in blood (protein), serum and tissue tests to diagnose and monitor cancer, today announced the change of the Company's official trading symbol from MLXG to PANG.

20 Jun 2011

Neogen announces acquisition of VeroMara

Neogen Corporation announced today that it has acquired the assets of the VeroMara seafood testing laboratory from its parent company, GlycoMar Ltd.

20 Jun 2011

Valencell receives $5.5M in Series B venture investment

Valencell, an innovator in mobile health and fitness technology, announced today that it has received $5.5 million in Series B venture investment. The round was led by Best Buy Capital, the investment group of Best Buy Co., Inc., with participation from Series A investors TDF and True Ventures.

20 Jun 2011

Medidata to acquire Clinical Force

Medidata Solutions, a leading global provider of SaaS-based clinical development solutions, today announced that it has entered into a definitive agreement to acquire Clinical Force, a pioneer in providing SaaS-based clinical trial management systems (CTMS), for undisclosed proceeds.

20 Jun 2011

CarePoint acquires infusion business of ArTex Medical

Waud Capital Partners announced that its portfolio company, CarePoint Partners, has acquired the infusion business of ArTex Medical, Inc., marking its 13th acquisition in under four years.

20 Jun 2011

Neovasc first quarter revenues increase 10% to $1,169,920

Neovasc Inc., today announced financial results for the three months ended March 31, 2011 and advances in its product development programs.

20 Jun 2011

Premier healthcare honors Toshiba with Supplier Performance Award

Toshiba America Medical Systems, Inc. today announced that it is a winner of the sixth annual Performance Award, presented by the Premier healthcare alliance.

20 Jun 2011

Chengdu Tianyin files renewal application for High Tech Enterprise Status

Tianyin Pharmaceutical Co., Inc., a pharmaceutical company that specializes in patented biopharmaceutical medicine, modernized traditional Chinese medicine, branded generics and active pharmaceutical ingredients today announced that the operating subsidiary of TPI, Chengdu Tianyin Pharmaceutical, has submitted the application for the renewal of its High Tech Enterprise Status at Chengdu, Sichuan Province of China.

20 Jun 2011

Pharma IQ publishes results of Industry-wide distribution survey

Pharma IQ has just published the results of an Industry-wide Pharmaceutical Distribution Survey, conducted recently among 3,000 pharmaceutical distribution specialist with over 83 % of those surveyed directly responsible for distribution at their respective companies.

20 Jun 2011

EpiCept announces results of 2011 stockholders annual meeting

EpiCept Corporation announced today the results of its 2011 Annual Meeting of Stockholders held on June 14, 2011.

20 Jun 2011

GenMark prices public offering of common stock

GenMark Diagnostics, Inc., a molecular diagnostics company focused on developing and commercializing proprietary eSensor detection technology, announced today the pricing of a public offering of 7,065,600 shares of its common stock at a price to the public of $4.25 per share.

17 Jun 2011

NASDAQ halts Regeneron's common stock

Regeneron Pharmaceuticals, Inc. announced that NASDAQ has halted trading of the company's common stock.

17 Jun 2011

CBAI acquires assets of NeoCells for $320,000

Cord Blood America, Inc., the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells to families nationwide and internationally, is pleased to announce that it has acquired the assets of NeoCells, a subsidiary of ViviCells International, Inc., Evanston, Illinois, through a foreclosure procedure at a purchase price of $320,000.

17 Jun 2011

Enterologics to acquire BioBalance from NYHC

Enterologics, Inc. announced today that it is acquiring all the shares of The BioBalance Corporation and its subsidiary BioBalance LLC from New York Health Care, Inc.

17 Jun 2011